Novo Integrated Sciences Total Non-Cash Items 2012-2024 | NVOS
Novo Integrated Sciences total non-cash items from 2012 to 2024. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
| Novo Integrated Sciences Annual Total Non-Cash Items (Millions of US $) |
|
|---|---|
| 2024 | $12 |
| 2023 | $11 |
| 2022 | $28 |
| 2021 | $3 |
| 2020 | $5 |
| 2019 | $0 |
| 2018 | $1 |
| 2017 | $0 |
| 2016 | $0 |
| 2016 | $0 |
| 2015 | $3 |
| 2014 | $1 |
| 2013 | $0 |
| 2012 | $1 |
| 2012 | $0 |
| 2011 | $1 |
| 2011 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.001B | $0.013B |
| Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $19.868B | 19.58 |
| Encompass Health (EHC) | United States | $12.183B | 25.83 |
| DaVita (DVA) | United States | $10.978B | 15.44 |
| Chemed (CHE) | United States | $8.483B | 26.66 |
| Elanco Animal Health (ELAN) | United States | $6.417B | 13.74 |
| Option Care Health (OPCH) | United States | $5.441B | 24.25 |
| RadNet (RDNT) | United States | $4.587B | 291.14 |
| Amedisys (AMED) | United States | $3.105B | 20.89 |
| LifeStance Health (LFST) | United States | $2.271B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.054B | 22.55 |
| Astrana Health (ASTH) | United States | $1.524B | 37.75 |
| U.S Physical Therapy (USPH) | United States | $1.213B | 31.31 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.169B | 66.56 |
| Pennant (PNTG) | United States | $1.042B | 38.25 |
| Atai Life Sciences (ATAI) | Germany | $0.331B | 0.00 |
| Daxor (DXR) | United States | $0.037B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |